In vivo reprogramming for heart disease

Cell Research

Volumn 22, Issue 11, 2012, Pages 1521-1523

  Xu, Huansheng ^a,b   Yi, B Alexander ^a,b   Chien, Kenneth R ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSDIFFERENTIATION; CYTOLOGY; FIBROBLAST; HEART; HEART FAILURE; HEART MUSCLE CELL; HUMAN; METHODOLOGY; NUCLEAR REPROGRAMMING; PHYSIOLOGY; REGENERATION; REGENERATIVE MEDICINE;

CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSDIFFERENTIATION; FIBROBLASTS; HEART; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; MYOD PROTEIN; NUCLEAR REPROGRAMMING; REGENERATION; REGENERATIVE MEDICINE;

EID: 84868517291     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2012.101     Document Type: Article

References (15)

1. Ptaszek LM, Mansour M, Ruskin JN, Chien KR. Towards regenerative therapy for cardiac disease. Lancet 2012; 379:933-942.
2. Qian L, Spencer CI, C Ian Spencer, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012; 485:593-598.
3. Song K, Luo X, Qi XQ, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012; 485:599-604.
4. Asuelime GE, Shi Y. A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicine. J Mol Cell Biol 2012; 4:190-196.
5. Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010; 142:375-386.
6. Zhou Q, Melton DA. Extreme makeover: converting one cell into another. Cell Stem Cell 2008; 3:382-388.
7. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science 2006; 313:1922-1927. (Pubitemid 44497993)
8. Chen JX, Krane M, Deutsch MA, et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res 2012; 111:50-55.
9. Protze S, Khattak S, Poulet C, et al. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol 2012; 53:323-332.
10. Jayawardena TM, Egemnazarov B, Finch EA, et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res 2012; 110:1465- 1473.
11. Modlich U, Baum C. Preventing and exploiting the oncogenic potential of integrating gene vectors. J Clin Invest 2009; 119:755-758.
12. Donahue JK. Gene therapy for ventricular tachyarrhythmias. Gene Ther 2012; 19:600-605.
13. Domian IJ, Chiravuri M, van der Meer P, et al. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 2009; 326:426-429.
14. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25:1015-1024. (Pubitemid 47517637)
15. van Laake LW, Passier R, den Ouden K, et al. Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size. Stem Cell Res 2009; 3:106-112.